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Urinary Angiostatin: A Potential Biomarker for Diagnosis and Evaluation
of Disease Severity in IgA Nephropathy
R. Bu, G. Y. Cai, Q. Zhang, S. Liang, Y. Lu, Z. X. Li, X. G. Zhang, J. Wu,
S. W. Liu, X. M. Chen
Department of Nephrology, Chinese PLA General Hospital, State Key
Laboratory of Kidney Diseases, National Clinical Research Center of Kidney
Diseases, Beijing, China
Objective: Currently, diagnosis of IgA nephropathy (IgAN) relies on renal bi-
opsy. Most IgAN is progressive, however, renal biopsy cannot be done
frequently for its invasive property. This study is to investigate non-invasive
protein biomarkers of IgAN from urine supernatant.
Methods: Urine supernatant was collected from 15 IgAN patients (Lee’s
grade I-II, III and IV-V, 5 in each group), 12 none-IgAN glomerular disease con-
trol (DC) patients (MCD, MN and FSGS, 4 in each group) and 5 normal control
(NC). Urine sample were analyzed by Raybiotech protein array for searching
differential expression of protein biomarkers. Candidate protein biomarkers
were further validated in urine samples from other subjects, including 49
IgAN patients (Lee’s grade I-II 8, grade III 31 and grade IV-V 10), 28 DC pa-
tients (MCD 8, MN 8 and FSGS 12) and 14 NC by ELISA method.
Results: Angiostatinwas found differential expressed between IgAN group and
control groups by protein array. By ELISA verification, the level of angiostatin
was significantly higher in IgAN group than NC group (255.15 288.43 vs
3.31 5.96), but lower than DC group, including MN (579.47 211.69 ng/ml)
and MCD (664.56 375.95 ng/ml). Angiostatin showed a significant positive
correlation with SCr (rZ 0.939), BUN (rZ 0.931), Cys C (rZ 0.923), protein-
uria (r Z 0.784), global sclerosis (r Z 0.718) and crescentformation
(rZ 0.588). There was a negative correlation between angiostatin level and
eGFR (rZ0.721). Angiostatin level in IgAN Lee’s grade IV-V groupwas signif-
icantly higher than gradeI-II and grade III group (620.43 271.47 vs
107.38 83.37 vs 117.89 143.84 ng/ml, p < 0.01). The level of angiostatin
was significantly higher in IgAN group with endothelial cell proliferation
change than those without (406.95 336.56 vs 189.41 234.70, p < 0.01).
Conclusion: Urine supernatant angiostatin could be used as a candidate
biomarker for diagnosis of IgAN. Angiostatin level reflects the clinical and
pathological features of IgAN.http://dx.doi.org/10.1016/j.hkjn.2015.08.093
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Objective: Most of IgA nephropathy (IgAN) is chronic progressive glomerulo-
nephritis, with different clinical and pathological features. Evaluation of the
disease by repeated renal biopsy is not practical due to its invasive proce-
dure. Urinary sediment miRNAs are hopeful to serve as non-invasive bio-
markers to assess kidney injury of IgAN.
Methods: 52 biopsy-proven IgAN patients and 25 healthy controls were
enrolled in this study. Urinary sediment miRNAs were extracted. Expressions
of miR-34a, miR-205, miR-21, miR-146a and miR-155 were quantified by
qPCR. ROC (receiver operating characteristic curve) was used to investigate
the value of the miRNAs for predicting dignosis of IgAN and evaluating histo-
pathological injury. The patients were treated according to the KDIGO guide-
line and followed up. The roles of miRNAs in reflecting theraputic efficacy
and disease progression were analyzed.
Results: (1) The IgAN group had significantly lower urinary miR-34a, miR-205,
miR-155 but higher miR-21 levels than controls. Logistic regression analysis
showed that urinary miR-34a0.047, miR-2050.209 and miR-210.461were independent factors for diagnosis of IgAN. The ROC revealed that miR-
2050.125 and miR-210.891 can distinguish IgAN patients with moderate
and severe tubular atrophy and interstitial fibrosis from those with mild
tubular atrophy and interstitial fibrosis. (2) After 21.17 months follow-up,
the level of proteinuria reduction (g/24h/month) was positively correlated
with baseline urinary miR-21 and inversely correlated with miR-205. The sub-
jectswho achieved a complete remission (CR) hadhigher baseline urinarymiR-
205, and lower miR-21 than those without achieveing a CR.
Conclusion: The levels of some urinary sediment miRNAs, especially baseline
miR-21 and miR-205 may be used as prognostic markers for evaluating the
tubulointerstitial damage of IgAN. What’s more, baseline levels of urinary miR-
NAs may be predictors to reflect theraputic efficacy and disease progression.http://dx.doi.org/10.1016/j.hkjn.2015.08.094
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Objective: Mesangial deposition of aberrantly glycosylated IgA1 (agIgA1) and its
immune complex is an initial and key pathogenicmechanism in IgA nephropathy
(IgAN). The present study tested the hypothesis that bacteria-derived IgA prote-
asesmaybeabletodegrade thecirculatinganddepositedagIgA1and its immune
complex locally in the mesangium and may represent a novel therapy for IgAN.
Methods:Wefirst identified bacterial IgA proteases with high enzymatic activ-
ity by screening 14 different bacterial strains (6 species totally). Among them,
4 IgA proteases were selected and their ability to degrade agIgA1 and its im-
mune complex was determined in vitro with artificially deglycosylated IgA1
or human IgAN biopsy and in vivo in a modified mouse model of passive IgAN.
Results: Selected bacteria-derived IgA proteases were capable of degrading
serum agIgA1 and normal IgA1 pretreated with neuraminidase and b-galacto-
sidase in vitro and also the deposited immune complex within the mesangium
of renal biopsy from IgAN patients. In a modified mouse model of passive IgAN
with abundant in situ mesangial deposition of the agIgA-IgG immune complex
in glomeruli, a single intravenous injection of bacterial IgA protease was able
to effectively degrade the deposited immune complex within the glomerulus.
Conclusion: The bacteria-derived IgA protease is a biologically active
enzyme that can specifically degrade serum agIgA systemically and the
deposited agIgA-IgG immune complex locally. Thus, the use of IgA protease
may represent a novel therapy for IgAN.http://dx.doi.org/10.1016/j.hkjn.2015.08.095
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Objective: It has been reported that Helicobacter pylori infection is involved
in the pathogenesis of IgA nephropathy (IgAN). However, the exact mecha-
nism remains unclear. In this study, we set to investigate the impact of cyto-
toxin-associated antigen A (CagA), one of the major toxins in H. pylori, on
the proliferation and extracellular matrix synthesis and secretion in cultured
rat glomerular mesangial cells (RGMC).
Methods: The RGMC cells were cultured in medium containing CagA of
different concentration (0, 1, 2, 4 mg/ml) for different time (24, 48, 72 hours)
followed by proliferation assay by CCK8 and quantitative analysis of extracel-
lularmatrix secretion (Collagen I and III). Theoptimal combination ofCagA con-
centration and treatment time was chosen to stimulate RGMC cells and
expression of cell proliferation associated molecules (BAX, Bcl-2, PCNA) and
intracellular collagen protein synthesis (Collagen I and III) were checked by
RT-PCR, western blot and immunohistochemical staining.
Results: CagA stimulated proliferation of RGMC as well as Collagen I and III
secretion in culture medium in a dosage and time-dependent way. Compared
with the control, 4 mg/ml of CagA significantly promoted proliferation and
Collagen I and III secretion as IL-1 (10 ng/ml). Furthermore, immunohisto-
chemical staining showed increased PCNA expression in RGMC upon CagA
stimulation. RT-PCR and western blot also validated the elevated mRNA
and protein level of BAX, Bcl-2, Collagen I and III.
Conclusion:CagA directly promotes rat glomerularmesangial cell proliferation
and extracellular matrix protein synthesis and secretion, indicating an under-
lyingmechanism for H. pylori infection associated with kidney damage in IgAN.http://dx.doi.org/10.1016/j.hkjn.2015.08.096
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Objective: We investigated the distinctive clinicopathological characteris-
tics of Chinese IgA nephrology (IgAN) population with acute kidney injury
(AKI) and tried to exam the association between AKI and renal outcome.
Methods: We performed a retrospective analysis of 1512 patients who were
biopsy-proven IgAN in the period 2006 through 2011 in our center. AKI was
defined as 2012 KDIGO (Kidney Diseases: Improving Global Outcomes)
criteria, we divided patients into AKI group (n Z 145) and non-AKI group
(nZ 1367) in cross-section analysis. There were 82 AKI and 906 non-AKI pa-
tients who had been regularly followed up until December 31, 2013. The pri-
mary composite endpoint was renal progression (including doubling of serum
creatinine or end-stage renal disease or start of renal replacement therapy).
Results: The prevalence of AKI in our center was 9.59% (145/1512). The clin-
icopathologic features were much more severe in AKI group (P < 0.05).
Acute tubulointerstitial nephritis (9.7%) was the most predominant intrinsic
renal injuries in Chinese IgAN population with AKI instead of macroscopic he-
maturia related acute tubular injury/necrosis. In multivariate logistic
regression analysis, we found that older age, male gender, malignant hyper-
tension, pre-existing impaired kidney function, proteinuria, cellular cres-
cent, fibrocellular crescent, glomerular sclerosis  50% were possible risk
factors for AKI. The cumulative survival rates without renal progression at
1-year, 3-year, and 5-year was 98.0% versus 83.4%, 93.5% versus 64.0%,
88.2% versus 35.3% respectively between non-AKI and AKI group. A Cox pro-
portional hazard model showed that pre-existing impaired kidney function
[hazard ratio (HR) 2.577, 95% confidence interval (CI) 1.16 to 5.73;
P Z 0.020], glomerular sclerosis50% [HR 3.34, 95% CI 1.30 to 8.58;
PZ 0.012] might possible risk factors for renal outcome among IgAN patients
with AKI.
Conclusion: AKI is commonly seen among IgAN population. We found that
acute tubulointerstitial nephritis was the most predominant pathologicalchange of intrinsic AKI. IgAN patients with AKI had significantly worse renal
outcome.http://dx.doi.org/10.1016/j.hkjn.2015.08.097
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Objective: To analyze the clinicopathological characteristics and relevant
factors of IgA nephropathy (IgAN) patients with hypertensive crisis.
Methods: This is a single center, retrospective, cohort study. All the patients
who were biopsy-proven primary IgAN in the period 2006 through 2011 in our
center and presented with hypertension were enrolled in this study and were
divided into two groups according to whether presenting hypertensive crisis.
The clinicopathological features were compared and the associated factors
of hypertensive crisis were evaluated by logistic regression.
Results: A total of 598 eligible IgAN patients with hypertension were enrolled
in the study. The incidence of hypertensive crisis was 4.2% (nZ 25). Male pa-
tients were 55.5% and mean age was 36.1 11.2 years old in all patients,
which showed no significantly different between the two groups. Patients
with hypertensive crisis had lower eGFR (36.6 30.0 mL/min/1.73 m2) and
hemoglobin (115.5 27.1 g/l) than patients without it (65.8 43.1 mL/
min/1.73 m2 and 125.6 24.0 g/l respectively). Moreover, patients with hy-
pertensive crisis exhibited higher proportions of CKD stage 5 (28.0%),
abnormal glucose metabolism (24.0%), hyperuricemia (76.2%), tubular atro-
phy/interstitial fibrosis (88%), interstitial inflammation (60.0%), arteriolar
wall thicken (80.0%) and capillary thrombosis (24.0%), 12.2%, 10.8%, 53.6%,
49.6%, 33.0%, 54.5% and 6.1% respectively in patients without hypertensive
crisis. Impressively, the difference of proteinuria was not statistically signif-
icant. In addition, multivariate logistic regression indicated that abnormal
glucose metabolism (OR Z 2.517, p Z 0.049), tubular atrophy/interstitial
fibrosis (OR Z 6.448, p Z 0.021) and capillary thrombosis (OR Z 7.266,
p Z 0.004) were independently associated with hypertensive crisis.
Conclusion: The incidence of hypertensive crisis was 4.2%. IgAN patients with
hypertensive crisis had worse clinicopathological features. Abnormal glucose
metabolism, tubular atrophy/interstitial fibrosis and capillary thrombosis
were risk factors of hypertensive crisis in IgAN patients with hypertension.http://dx.doi.org/10.1016/j.hkjn.2015.08.098
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Objective: We conducted a study to compare the clinicopathological fea-
tures and to identify the potential factors associated with the renal
outcome.
Methods: This was a retrospective cohort study, and a total of 1570 IgA pa-
tients were included. We evaluated the demographic, clinical and pathological
characteristics of 1570 IgAN patients with different levels of kidney function.
Unadjusted and adjusted logistic regression models were used to evaluate the
association of clinicopathological characteristics and kidney function.
Results: Of the 1570 IgAN patients enrolled in this study, there were 1,146
patients with estimated glomerular filtration rate (eGFR)  60 mL/min/
